These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9447603)

  • 1. Lead validation platforms.
    Persidis A
    Nat Biotechnol; 1998 Jan; 16(1):100-1. PubMed ID: 9447603
    [No Abstract]   [Full Text] [Related]  

  • 2. Lead validation platforms.
    Nat Biotechnol; 2000 Oct; 18 Suppl():IT47-9. PubMed ID: 11221718
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug discovery: the leading edge.
    Chapman T
    Nature; 2004 Jul; 430(6995):109-15. PubMed ID: 15229608
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for drug discovery: the leading question.
    Smith A
    Nature; 2002 Jul; 418(6896):453-9. PubMed ID: 12140563
    [No Abstract]   [Full Text] [Related]  

  • 5. Global trends in the pharmaceutical industry.
    Albers-Schönberg G
    P R Health Sci J; 2002 Jun; 21(2):85-9. PubMed ID: 12166029
    [No Abstract]   [Full Text] [Related]  

  • 6. Redefining priorities in gene-based drug discovery.
    Khodadoust MM; Klein TP
    Nat Biotechnol; 2001 Aug; 19(8):707. PubMed ID: 11479549
    [No Abstract]   [Full Text] [Related]  

  • 7. China's unique position in discovery and preclinical research.
    Boutellier R; Ullman F
    Drug Discov Today; 2007 Jan; 12(1-2):4-7. PubMed ID: 17198968
    [No Abstract]   [Full Text] [Related]  

  • 8. Lab automation and robotics: Automation on the move.
    Chapman T
    Nature; 2003 Feb; 421(6923):661, 663, 665-6. PubMed ID: 12571603
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for success.
    Mahapatra A
    ACS Chem Biol; 2008 Aug; 3(8):449-50. PubMed ID: 18707052
    [No Abstract]   [Full Text] [Related]  

  • 10. Testing time for stem cells.
    Baker M
    Nature; 2010 Feb; 463(7282):719. PubMed ID: 20148005
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro models for in vivo drug profiles.
    Kling J
    Nat Biotechnol; 1996 Dec; 14(13):1655-6. PubMed ID: 9634846
    [No Abstract]   [Full Text] [Related]  

  • 12. Using genetically engineered mouse models of cancer to aid drug development: an industry perspective.
    Singh M; Johnson L
    Clin Cancer Res; 2006 Sep; 12(18):5312-28. PubMed ID: 17000664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A testing approach based on tiny doses still awaits big results.
    Coombs A
    Nat Med; 2008 Aug; 14(8):796. PubMed ID: 18685584
    [No Abstract]   [Full Text] [Related]  

  • 14. Compound library management. An overview of an automated system.
    Keighley WW; Wood TP
    Methods Mol Biol; 2002; 190():129-52. PubMed ID: 12029819
    [No Abstract]   [Full Text] [Related]  

  • 15. Promises of biomarkers in drug development--a reality check.
    Marrer E; Dieterle F
    Chem Biol Drug Des; 2007 Jun; 69(6):381-94. PubMed ID: 17581232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High throughput screening: early successes indicate a promising future.
    Fox S; Wang H; Sopchak L; Khoury R
    J Biomol Screen; 2001 Jun; 6(3):137-40. PubMed ID: 11689109
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell signalling: making connections.
    Gershon D
    Nature; 2004 Nov; 432(7014):243-9. PubMed ID: 15538373
    [No Abstract]   [Full Text] [Related]  

  • 18. Brave new pharmacy.
    Lemonick MD
    Time; 2001 Jan; 157(2):58-66, 69. PubMed ID: 11195690
    [No Abstract]   [Full Text] [Related]  

  • 19. Image-based chemical screening.
    Carpenter AE
    Nat Chem Biol; 2007 Aug; 3(8):461-5. PubMed ID: 17637778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of systems approaches on biological problems in drug discovery.
    Hood L; Perlmutter RM
    Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.